trial acronym

trial acronym

A clinical trial protocol title which is usually an acronym of the key elements of the trial.
References in periodicals archive ?
Trials identified in the SLR and the reasons for their inclusion/exclusion in this MAIC Trial acronym Intervention Comparator CLEAR Secukinumab 300 Ustekinumab 45 mg (subanalysis) mg (s.c.); weeks 0, 1, 2, for individuals and 3 and Q4W [less than or equal to]100 from week 4 kg and 90 mg for individuals >100 kg (s.c.); weeks 0, 4, and Q12W from week 16 ERASURE Secukinumab 300 Placebo (subanalysis) mg or 150 mg give at weeks 0, 1, 2, 3, and 4 and Q4W thereafter through week 48 FIXTURE Secukinumab 300 Placebo (subanalysis) mg or 150 mg QW for 4 weeks FUTURE 1 Secukinumab 10 Placebo: i.v.